In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...